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Despite concerted efforts, diagnosis of aspergillosis is still a great challenge to clinical 
microbiology laboratories. Along with the requirement for high sensitivity and 
specificity, species-specific identification is important. We developed rapid, sensitive 
and species-specific qPCR assays using the TaqMan technology for the detection and 
identification of Aspergillus fumigatus and Aspergillus terreus. The assays were 
designed to target orthologs of the Streptomyces factor C gene that are only found in a 
few species of filamentous fungi. Fungi acquired this gene through horizontal gene 
transfer and divergence of the gene allows identification of species. The assays have 
potential as a molecular diagnosis tool for the early detection of fungal infection caused 
by Aspergillus fumigatus and Aspergillus terreus, which merits future diagnostic 


















Certain species of the fungal genus Aspergillus are able to cause diseases in humans, 
especially in those with impaired immune system/immunocompromissed patients. 
Besides the standard risk groups for invasive aspergillosis (IA), which include 
neutropenic, leukemic patients and patients receiving hematopoietic stem cell and solid 
organ transplantation there is a growing trend in the number of systemic invasive fungal 
infections associated with new advances in modern medicine using aggressive 
immunosuppressive regimens [1-3]. 
In these patients IA is very common and the mortality rate is high [4-5]. The most 
frequent human pathogen that causes aspergillosis is A. fumigatus, responsible for about 
90% of all cases [6] but other Aspergillus species including A. terreus, A. flavus, A. 
niger may also cause the disease [7, 8]. Studies have also described Neosartorya [9] and 
Chaetomium [10] species causing aspergillosis. 
Surviving IA depends on the early diagnosis of infection and the proper and timely 
initiation of antifungal therapy. Based on this there is an urgent need for standardized, 
reliable diagnostic methods with maximum specificity and sensitivity. 
Diagnosis of IA is difficult using microbiological and histological methods that are time 
consuming and usually verify the disease at autopsy. Furthermore, the initiation of 









[11]. Signs and symptoms of systemic diseases caused by Aspergillus species are non-
specific and patients are often unable to undergo invasive diagnostic procedures. 
The main non-invasive diagnostic techniques for IA include the detection of surrogate 
biomarkers; galactomannan [12] or β-D-glucan [13] antigens that are common cell wall 
components of fungal cells, or fungal DNA, usually the rRNA genes or their internal 
transcribed spacer regions, circulating in the blood [14]. 
An interesting new approach is the amplification of circulating fungal mRNA that 
represents viable fungal cells [15, 16]. Recently antigen-capture ELISA has been used 
for the detection of new fungal biomarker molecules [17, 18]. Despite these approaches, 
there is no generally accepted molecular method available for the early and reliable 
diagnosis of IA, therefore exploration of new possibilities is essential. 
Here we describe novel and sensitive qPCR assays for the detection and identification 
of Aspergillus fumigatus and A. terreus. The assays are based on the quantification of 
fungal orthologs of the Streptomyces facC gene.  
In the soil, fungi compete with filamentous bacteria such as Streptomyces. Interestingly, 
we discovered a gene in various Aspergillus species that has strong similarity to facC 
gene for the signaling protein factor C found in several Streptomyces [19]. The fact that 
codon usage is the same as in streptomycetes suggests that it was acquired via 
horizontal gene transfer [20]. Only some fungi have orthologs, allowing identification 
with high fidelity, while the strong sequence divergence between the orthologs in 










Materials and methods 
 
Growth of the strains and isolation of genomic DNA 
 
Aspergillus fumigatus AF293 and Aspergillus terreus NCCB IH2624 strains were 
cultivated on standard minimal nitrate medium [21]. Freshly isolated (A. fumigatus: 3 
days, A. terreus: 7 days) conidia were suspended in PBS–0.01% Tween 80, counted in a 
Bürker chamber and used in spiking experiments. 
Genomic DNA was isolated from liquid cultures grown in minimal medium at 37 °C (A. 
fumigatus) and 25 °C (A. terreus) at 220 rpm for 18 h. The mycelium was disrupted in 
liquid nitrogen [21] and DNA isolated using the Genomic DNA Purification Kit 
(Thermo Scientific, Maryland, USA) according to the manufacturer’s instructions. 
 
DNA extraction from biological samples spiked with conidia 
 
After the disruption of the fungal cell walls with the MagNA Lyser instrument using 
ceramic Green Beads for 90 sec at 5000 rpm (Roche Applied Science) fungal DNA was 
isolated by automated extraction with the MagNA Pure LC instrument. 1200 μl of 













fumigatus or A. terreus conidia. Samples were bead beaten with glass/ceramic beads 
and 1000 μl lysate was further processed for DNA extraction using the MagNa Pure LC 
Total Nucleic Acid Isolation Kit – Large Volume (Roche Applied Science) according to 
the manufacturer’s recommendations. DNAs were eluted in a volume of 50 μl. 
 
A. fumigatus and A. terreus TaqMan primers and probes 
 
A. fumigatus and A. terreus genomic DNA was used as template in the assays. There are 
two facC orthologous genes in A. fumigatus located on chromosomes 3 and 5. The copy 
on chromosome 3 (AFUA_3G14910 FacC-like extracellular signaling protein) was 
targeted with the following qPCR assay: forward primer: 5’-
CAAGCAGCCGGAGTTGGA-3’; reverse primer: 5’-
ACTGTCCATACGCTGCATAACC-3’; hydrolysis probe 5’FAM-
ACGCTGTCGTTGACTTT-MGB (MGB1 assay). These primers amplified a 62 bp 
DNA fragment.  
 
The copy on chromosome 5 (AFUA_5G00540 FacC-like extracellular signaling 
protein) was targeted with the following qPCR assay: forward primer: 5’-
AATCCCCGACTCTCCACGAT-3'; reverse primer: 5’-
TCCGCCAGAGGTCATACGA-3'; Hydrolysis probe 5'-FAM-









DNA fragment. In the dual detection reaction both copies of facC (located on 
chromosomes 3 & 5) were detected (MGB3 assay). 
 
Only a single copy of the facC orthologous gene (ATEG_03536 hypothetical protein 
similar to factor C protein precursor) is present in A. terreus. This was targeted using 
the following qPCR assay: forward primer: 5’-CGAATGGATACGGGAAGAAGCT-
3’; reverse primer: 5’-CGAGCGAGGCATCGGTATG-3’; hydrolysis probe 5’FAM-
TTGCCATTGACAAACTT-MGB (MGB4 assay). These primers amplified a 78 bp 
DNA fragment.  
 
Assay conditions  
 
The assays were run in 20 µl reactions containing: 10 µl TaqMan® Universal PCR 
Master Mix (2x) (Applied Biosystems); 1 or 2 µl TaqMan® gene expression assay(s) 
(20x Applied Biosystems) containing the forward and reverse primers (900 nM) and the 
FAM-labeled TaqMan-MGB probe (250 nM); 8 or 9 µl of DNA template. qPCR was 
performed on 7500 Real Time PCR platform (Applied Biosystems) with the following 
reaction parameters: Stage 1: UNG inactivation; 50°C, 2 min. Stage 2: denaturing DNA 
and Taq enzyme activation; 95°C, 10 min, Stage 3: 55 cycles of 95°C, 10 sec, 60°C 1 
min. Negative controls (NTC, non-template control) were 8 or 9 μl PCR grade water 









according to ISHAM EAPCRI consensus at least one positive result was enough to 
consider the sample as positive. 
 
Analytical sensitivity and specificity 
 
Serial dilutions of A. fumigatus or A. terreus genomic DNA (gDNA) was used as 
template to determine the analytical sensitivity of the assays. The concentrations of 
gDNA ranged from 17 ng to 85 fg which is equivalent of about 10
6
 to 5 genomic 
equivalents (GE); assuming that 1 GE of A. fumigatus and A. terreus corresponds to 17 
fg.  
 
The specificity of the assays was tested by adding 200 ng human genomic DNA to 
serial dilutions of A. fumigatus or A. terreus gDNA ranging from 17 ng to 17 pg 
 
The analytical specificity of the assays was further tested against a panel of several 
Aspergillus and other fungal species as well as bacterial strains listed in Table I. Some 
of these strains are known to contain factor C orthologs. 
 










To study the correlation between the threshold cycle number (Cq) of the qPCR and the 
genomic load standard curves were obtained by plotting Cq values against the log of 
genome number. PCR efficiency was calculated from the slopes of the curves by the 










Results and Discussion 
 
Aspergillus species involved in IA have Streptomyces facC orthologs 
 
Factor C was described as an extracellular signaling protein that affects morphological 
differentiation and antibiotic production in Streptomyces. Proteomic studies recently 
showed that it compensates for a mutation that led to almost complete abolishment of 
production of A factor and regulates the production of many sporulation specific 
proteins [22,23].  
At the time of the sequencing of its gene it was an orphan gene [19]. DNA hybridization 
experiments and the accumulation of genome sequencing data revealed only a few 
homologues genes in Streptomyces and fungal strains but the gene is far from being 
widely distributed even in these taxa [20]. Because of the high GC content of the fungal 
orthologous genes we hypothesize that the gene was acquired by the fungal strains by 
horizontal gene transfer from streptomycetes in their common ecological niche. It is 
reasonable to suppose that these filamentous soil microorganisms eat each other – 
streptomycetes possess batteries of chitinases that would help them to digest fungal 
walls, and many fungi make antibiotics active against bacterial cell wall biosynthesis, 
including β-lactams; and the fungal genes for β-lactam biosynthesis are themselves 









help filamentous fungal species in the competition with streptomycetes perhaps by 
increasing the rate of sporulation. In the fungal strains the facC genes diverged that 
makes them suitable for species specific identification. 
 
Analytical sensitivity and specificity of the assays 
 
The analytical sensitivity of the qPCR assays is shown in Figures 1. and 2. The limit of 
detection of single facC ortholog-specific assays was 127.5 fg (7.5 GE), while the 
analytical sensitivity of A. fumigatus-specific, dual-copy assay hybridizing to both 
chromosome 3 and 5 facC orthologs was 85 fg (5 GE).  
The limit of detection for the A. terreus assay was 170 fg (10 GE).  
The analytical sensitivity of the A. fumigatus and A. terreus assays was unaffected by 
the presence of high excess (200 ng) of human gDNA (data not shown). 
 
Neither of the A. fumigatus assays cross reacted with A. terreus DNA or human 
genomic DNA nor did the A. terreus assay cross reacted with A. fumigatus genomic 
DNA or human genomic DNA (results not shown). Testing the assays against a panel of 
DNA from a variety fungi and bacteria revealed no cross reactions (Table I) even in 
species that are known to contain factor C or facC orthologous genes such as 











PCR linearity and efficiency 
 
Standard curves derived from qPCR analysis of serial dilutions (17 ng to 85 fg) of 
gDNA were used to determine the linearity and efficiency of each assay. The PCR 
efficiencies for the A. fumigatus assays were 102.8%, 113.9% and 106.6% when the 
facC copy on chromosome 3, the facC copy on chromosome 5, or when both copies 
were detected. The efficiency of the A. terreus assay was 108.4%. The efficiency values 
of the qPCR assays are shown in Table II. 
These data are within the acceptable range. 
 
Testing the analytical sensitivity on blood samples 
 
The usefulness and efficiency of the MGB3 and MGB4 assays was tested on 1200 µL 
blood samples spiked with conidia. Although the blood of patients contains mycelial 
fragments rather than conidia in these experiments to measure the number of cells 
precisely we used conidia that are more difficult to disrupt. To test the assays in parallel 
experiments we also used mycelia spiked blood and both assays worked properly. The 
assays performed well in the range of 10
6
 to 10 conidia. The efficiency values of the 
Aspergillus fumigatus and A. terreus specific assays were; 89, 88% and 102.6%. R2 












Despite recent advances in diagnosis and treatment, aspergillosis is still a leading cause 
of death in immunocompromised individuals. Although the array of DNA-based 
molecular diagnostic tests that outperform the conventional methods has expanded over 
the past two decades, these platforms were not included in the European Organization 
for Research and Treatment of Cancer and the Mycoses Study Group (EORTC/MSG) 
consensus definitions because of the lack of standardization. It is clear that there is an 
urgent need to develop effective and reliable diagnostics for IA due to the continuing 
growth of publications working at incorporating DNA based applications into routine 
clinical diagnostics to reduce costs and to improve sensitivity and specificity 
respectively [25-31] and supporting diagnostic driven therapy. 
 
The species level identification of two of the most common causes of aspergillosis is 
also of great importance, since it is a prerequisite of the targeted antifungal therapy 
because different species respond differently to a given antifungal treatment. This also 
addresses a significant drawback of empirical therapies that assist the spread and 
development of drug-resistant fungi; additionally they expose the infected patient to 









In the case of A. fumigatus and A. terreus more than 10 independent isolates were tested 
and proved to contain the target facC gene. Furthermore in an international EAPCRI 
specificity panel study our assays proved to be specific for these two species. We 
believe that this is an indication that the facC orthologs are present in these species 
without sequence variation. Although only one isolate was tested from the other fungal 
strains we suppose that the gene is really absent from them e.i. testing many more 
isolates would also give similar results. 
The methods described in this study presents sensitive, species-specific, cost-effective 
qPCR assays for the detection of IA. The absence of false positive results may be 
explained by the rare occurrence of the investigated facC gene in fungi and by the 
relatively high guanine and cytosine (G+C) content of the gene. Although they are not 
multi-copy assays, there analytical sensitivity (5 to 10 GE) matches that of assays based 
on the detection of multi-copy rRNA genes [33]. In a direct comparison of the 
sensitivity our home-brewed real-time PCR A. fumigatus assay superseded the gold 
standard galactomannan assay. 
 
Since the assays are not based on the detection of fungal ribosomal RNA gene, they 
may also be used to verify results based on the detection of rRNA genes. This combined 
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Table I. Testing of species-specific real-time PCR assays against genomic DNAs from 
fungi, bacteria and human 
 
Strain Tested Factor C ortholog  
Target Gene 
AFUA_3G14910 AFUA_5G00540 ATEG_03536 
Aspergillus fumigatus 
Af293 and 8 other 
clinical isolates 
Present + + - 
Aspergillus terreus 
NCCB IH2624 and 2 
other isolates 
Present - - + 
Aspergillus nidulans Absent - - - 
Aspergillus niger Absent - - - 
Aspergillus 
brasiliensis 
Absent - - - 
Aspergillus lentulus Absent - - - 
Aspergillus flavus Absent - - - 
Aspergillus tamarii Absent - - - 
Aspergillus 
pseudotamarii 











Absent - - - 
Candida albicans Absent - - - 
Trichoderma reseii Absent - - - 
Penicillium 
chrysogenum 
Present - - - 
Escherihia coli Absent - - - 
Streptomyces 
albidoflavus 45H 
Present - - - 
Streptomyces griseus 
52-1 
Absent - - - 
Streptomyces lividans 
1326 
Absent - - - 
Streptomyces albus R-
55 
Present - - - 
Streptomyces 
flavofungini 
Present - - - 












Table II. Efficiency (%) and the coefficient of determination of the assays 
 







MGB1 -3.2569x+43,173 -3.2569 102.8 0.9987 
MGB2 -3.0274x+41,363 -3.0274 113.9 0.9979 
MGB3 -3.1558x+41,456 -3.1558 106.6 0.9972 













Figure 1.  
Determination of the analytical sensitivity of the TaqMan assays. 
(a) Assay MGB1, target gene Aspergillus fumigatus facC ortholog on chromosome 3. 
(b) Assay MGB2, target gene Aspergillus fumigatus facC ortholog on chromosome 5. 
(c) Assay MGB3, target gene Aspergillus fumigatus facC orthologs on chromosomes 3 
& 5.  
(d) Target gene Aspergillus terreus facC ortholog.  
Normalized fluorescence values as a function of cycle numbers are shown. Samples are 
a serial dilution of genomic DNA from A. fumigatus (a, b and c) or A. terreus (d): 1 = 
17 ng; 2 = 1.7 ng; 3 = 170 pg; 4 = 17 pg; 5 = 1.7 pg and 6 = 85 fg.  
 
Figure 2. 
Real-time PCR linearity and dynamic range.  
The linearity of the assays was achieved over a 5-log range of input from 17 ng to 85 fg 
gDNA.  
Aspergillus fumigatus MGB1 assay detecting the facC gene ortholog located on 
chromosome 3. LoD: 127.5 fg.  
Aspergillus fumigatus MGB2 assay detecting the facC gene ortholog located on 









Aspergillus fumigatus MGB3 assay detecting the facC orthologs located on 
chromosome 3 & 5. LoD: 85 fg. 
Aspergillus terreus MGB4 assay detecting the facC gene ortholog in the A. terreus 
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